Palantir Bioceuticals IncOver The Counter Market:IFAN
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0001 / 0.0001
- Day Range
- 52 Week Range
- Volume6,248
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IFAN |
|---|---|---|
| 09:32 ET | 6248 | 0.0001 |
Industry Peers
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Palantir Bioceuticals Inc | 100.4K | 0.0x | --- |
Rivex Technology Corp | 10.0 | 0.0x | --- |
Maptelligent Inc | 317.1K | -0.2x | --- |
Vubotics Inc | 50.0 | 0.0x | --- |
Telidyne Inc | 1.7K | 0.0x | --- |
Plyzer Technologies Inc | 120.0 | 0.0x | --- |
Company Information
Palantir Bioceuticals, Inc., formerly IFAN Financial, Inc., is a biopharmaceutical company offering holistic solutions to mental health illnesses. The Company uses psychedelic-assisted psychotherapy (PAP), supervised use of ketamine, 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, Lysergic acid diethylamide (LSD), and ibogaine as part of elaborated psychotherapy programs.
Contact Information
- Headquarters
- 5694 Mission Center Rd Ste 602-660SAN DIEGO, CA, United States 92108
- Phone
- 619-537-9998
- Fax
- ---
Executives
- President, Chief Executive Officer, Director
- J Christopher Mizer
- Chief Financial Officer, Treasurer, Secretary, Director
- Steve Scholl
- Director, Chief Technical Officer
- Chris Menya
- Director
- John De Puy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Palantir Bioceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
